SOX2 and central nervous system cancer: METTL3 expression promoted radioresistance in glioma by promoting glioblastoma stem cell maintenance through m6A-mediated stabilization of SOX2, and subsequent METTL3 knockdown resulted in increased radiosensitivity [39].